Omega-3 Fatty Acids (EPA/DHA) ： Ulcerative Colitis (UC)
CMixed results in maintaining UC remission. Some meta-analyses show modest benefit; others show no significant effect. EPA may be more beneficial than DHA.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'gutcited.com';
const params = 'ingredient\u003Domega\u002D3\u002Dfatty\u002Dacids\u0026condition\u003Dibd\u002Dulcerative\u002Dcolitis';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
C
結論
Mixed results in maintaining UC remission. Some meta-analyses show modest benefit; others show no significant effect. EPA may be more beneficial than DHA.
Key Study Findings
Review
Diet in Ulcerative Colitis: A Narrative Review of Its Role in Pathogenesis and Treatment.
Dose: None
vs: None
Outcome: None
効果: None
None
対象集団: patients with ulcerative colitis
Review
Gut microbiome-centric nutritional strategies in inflammatory bowel disease: Modulating dysbiosis for therapeutic benefit.
Dose: None
vs: None
Outcome: IBD microbiota modulation and immune regulation
効果: None
None
対象集団: IBD patients (review of nutritional interventions)
Review
Are there Effective Vegan-Friendly Supplements for Optimizing Health and Sports Performance? a Narrative Review.
Dose: None
vs: None
Outcome: Athletic performance and nutritional optimization
効果: None
None
対象集団: Vegan athletes (narrative review)
Review
From Evidence to Practice: A Narrative Framework for Integrating the Mediterranean Diet into Inflammatory Bowel …
Dose: None
vs: None
Outcome: None
効果: None
None
対象集団: None
Other
Interaction between diet and genetics in patients with inflammatory bowel disease.
Dose: None
vs: None
Outcome: Diet-genetics interaction in IBD
効果: None
None
対象集団: IBD patients (editorial commentary)
Review
Association between Omega-3 fatty acids and autoimmune disease: Evidence from the umbrella review and Mendelian …
Dose: None
vs: None
Outcome: Colitis severity
効果: None
None
対象集団: Crohn's disease patients
Key Statistics
8
研究数
1000
参加者数
↔
Mixed
C
グレード
Referenced Papers
Digestive diseases and …
2026
1 件の引用
Nutrients
2025
9 件の引用
Semergen
2025
4 件の引用
Current nutrition reports
2025
3 件の引用
Autoimmunity reviews
2024
12 件の引用
World journal of …
2024
Metabolites
2023
13 件の引用
Association between dietary acid load and the odds of ulcerative colitis: a case-control study.
Other
Scientific reports
2023
1 件の引用
Nutrients
2022
66 件の引用
Nutrients
2022
61 件の引用
Journal of medicinal …
2022
8 件の引用
Foods (Basel, Switzerland)
2021
96 件の引用
Nutrients
2021
27 件の引用
Scientific reports
2020
56 件の引用
Therapeutic advances in …
2020
21 件の引用
Redox modulatory protective effects of ω-3 fatty acids rich fish oil against experimental colitis.
Other
Toxicology mechanisms and …
2019
33 件の引用
Nutrients
2019
24 件の引用
Gastroenterology clinics of …
2018
67 件の引用
International journal of …
2017
143 件の引用
Medical principles and …
2017
45 件の引用
Ugeskrift for laeger
2017
Annals of gastroenterology
2016
80 件の引用
European journal of …
2016
79 件の引用
Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohn's Disease and Ulcerative Colitis.
Review
Current pharmaceutical design
2016
32 件の引用
Clinics in dermatology
2016
19 件の引用
World journal of …
2014
36 件の引用
World journal of …
2014
25 件の引用
Alimentary pharmacology & …
2013
128 件の引用
Nutritional modulators of ulcerative colitis: clinical efficacies and mechanistic view.
Systematic Review
World journal of …
2013
56 件の引用
The British journal …
2012
145 件の引用
Dietary supplements for established atopic eczema.
Meta-Analysis
The Cochrane database …
2012
130 件の引用
World journal of …
2012
113 件の引用
Frontline gastroenterology
2012
20 件の引用
Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature.
Systematic Review
The American journal …
2011
946 件の引用
Inflammatory bowel diseases
2011
195 件の引用
Nutrition in clinical …
2011
1 件の引用
JRSM short reports
2010
11 件の引用
Inflammatory bowel diseases
2008
77 件の引用
The Cochrane database …
2007
118 件の引用
Journal of food …
2007
49 件の引用
Nutrition (Burbank, Los …
2003
189 件の引用
Nutricion hospitalaria
2003
Journal of the …
2002
2016 件の引用
Nutrition (Burbank, Los …
2000
64 件の引用
Drugs
1998
99 件の引用
The American journal …
1998
84 件の引用
Bailliere's clinical gastroenterology
1997
26 件の引用
Langenbecks Archiv fur …
1995
3 件の引用
The American journal …
1992
260 件の引用
The American journal …
1991
2278 件の引用
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
一般的な使用量
- general:
- 1,000-2,000 mg combined EPA/DHA per day
- ibdsupport:
- 2,000-4,000 mg/day combined EPA/DHA (higher EPA ratio may be more beneficial)
上限量： 3,000 mg/day combined EPA/DHA (FDA GRAS limit)
研究で検討された用量
| 用量 | 期間 | 効果 | N |
|---|---|---|---|
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
| None | -- | Neutral | -- |
| None | -- | Neutral | -- |
| 95% | -- | Mixed | -- |
| 95% | -- | Mixed | 124 |
推奨摂取タイミング： With meals containing fat for better absorption
Safety & Side Effects
報告されている副作用
- ⚠ Fishy aftertaste and burping
- ⚠ Mild gastrointestinal discomfort (nausea, diarrhea)
- ⚠ Potential increased bleeding time at very high doses (>3 g/day)
- ⚠ May lower blood pressure slightly
既知の相互作用
- ● Anticoagulants and antiplatelet drugs (may increase bleeding risk at high doses)
- ● Blood pressure medications (additive hypotensive effect)
- ● Orlistat (may reduce omega-3 absorption)
- ● Cyclosporine (fish oil may reduce cyclosporine nephrotoxicity but monitor levels)
耐容上限摂取量： 3,000 mg/day combined EPA/DHA (FDA GRAS limit)
サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。
Frequently Asked Questions
Does Omega-3 Fatty Acids (EPA/DHA) help with Ulcerative Colitis (UC)?
Based on 8 studies with 1,000 participants, there is limited but promising evidence that Omega-3 Fatty Acids (EPA/DHA) may support Ulcerative Colitis (UC) management. Our evidence grade is C (Some Evidence).
How much Omega-3 Fatty Acids (EPA/DHA) should I take for Ulcerative Colitis (UC)?
Studies have used various dosages. A commonly studied range is 1,000-2,000 mg combined EPA/DHA per day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Omega-3 Fatty Acids (EPA/DHA)?
Reported side effects may include Fishy aftertaste and burping, Mild gastrointestinal discomfort (nausea, diarrhea), Potential increased bleeding time at very high doses (>3 g/day), May lower blood pressure slightly. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Omega-3 Fatty Acids (EPA/DHA) and Ulcerative Colitis (UC)?
We rate the evidence as Grade C (Some Evidence). This rating is based on 8 peer-reviewed studies with 1,000 total participants. The overall direction of effect is mixed.
Related Evidence
に関する他の成分： Ulcerative Colitis (UC)
Omega-3 Fatty Acids (EPA/DHA) 他の症状・状態について
FDAに関する免責事項: これらの記述は米国食品医薬品局（FDA）による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。